Toi M, Takayanagi T, Souma R, Tominaga T
Oncol Rep. 1994 Mar;1(2):423-6.
It is known that an anti-angiogenic compound AGM-1470 inhibits cells in vitro and in vivo, on mitogen-induced cell growth in capillary endothelial cells. In monolayer cultures, 1 ng/ml AGM-1470 completely inhibited both basic fibroblast growth factor (bFGF) induced cell growth and vascular endothelial growth factor (VEGF) induced cell growth in a cytostatic manner. IC50 was 85 pg/ml and 55 pg/ml for bFGF and VEGF induced cell growth, respectively. Moreover, in collagen gels, AGM-1470 suppressed the colony formation induced by bFGF and by VEGF in a dose dependent manner. Few colonies appeared 25 days after co-culuture with I ng/ml AGM-1470 and either 1 ng/ml bFGF or 5 ng/ml VEGF. It is suggested that a potent; inhibition of growth signals of more than one growth factor for endothelial cells might be involved in anti-angiogenic activity of AGM-1470.
已知抗血管生成化合物AGM - 1470在体外和体内均能抑制有丝分裂原诱导的毛细血管内皮细胞的生长。在单层培养中,1 ng/ml的AGM - 1470以细胞生长抑制的方式完全抑制了碱性成纤维细胞生长因子(bFGF)诱导的细胞生长和血管内皮生长因子(VEGF)诱导的细胞生长。bFGF和VEGF诱导的细胞生长的IC50分别为85 pg/ml和55 pg/ml。此外,在胶原凝胶中,AGM - 1470以剂量依赖的方式抑制bFGF和VEGF诱导的集落形成。与1 ng/ml AGM - 1470以及1 ng/ml bFGF或5 ng/ml VEGF共培养25天后,几乎没有集落出现。这表明AGM - 1470的抗血管生成活性可能涉及对内皮细胞多种生长因子生长信号的有效抑制。